Dorsal Vetilation and PPCs in Colorectal Cancer Surgery Patients
Intraoperative Reduction of Ventilation of Dorsal Lung Regions and Postoperative Pulmonary Complications After Laparoscopic Colorectal Cancer Surgery
1 other identifier
observational
92
1 country
1
Brief Summary
Postoperative pulmonary complications (PPCs) are common in patients after major abdominal surgery. It has been shown that 5-40% of patients occur PPCs after major surgery, and the mid to high PPC rate is observed after laparoscopic colorectal cancer surgery. PPCs are associated with poor clinical outcomes including prolonged hospital length of stay and increased morbidity and mortality. Mechanical ventilation during general anesthesia can lead to a redistribution of ventilation, increase the aereation in the ventral parts of the lung, whereas reduce ventilation in the dorsal parts of the lung compared with spontaneous breathing (SB) in the awake state in supine position. The reduction of ventilation of dorsal lung regions indicates the presence of dorsal atelectasis during mechanical ventilation after general anesthesia, which may be associated with PPCs. However, there is still no evidence to reveal the association between the reduction of dorsal ventilation and PPCs. Recently, electrical impedance tomography (EIT), which allows visualization of lung ventilation in real time, and assessment of regional lung ventilation. It is feasible to assess the change of ventral/dorsal lung ventilation during the surgery using EIT. To date, no study has investigated whether the change of ventral/dorsal lung ventilation revealed by EIT could be associated with PPCs. So, this prospective observational study aims to clarify whether patients developing postoperative pulmonary complications had higher reduction of dorsal lung ventilation during operation after general anesthesia as compared to patients not developing postoperative pulmonary complications. Ratio of dorsal ventilation during spontaneous respiration (T0) in the awake state as a reference, the proportion of dorsal ventilation after anesthesia induction and endotracheal intubation (T1), body position change and capnoperitoneum (T2), and at the end of surgery (T3) were analyzed. Thereafter, evaluating the change of dorsal ventilation in patients with PPCs and without PPCs at different time points. According to the method of sample size calculation published by Scaramuzzo G et al. (Anesthesiology. 2024 Oct 1;141(4):693-706.). A minimum sample size required for this study was calculated as following: using the difference of reduction of dorsal ventilation at the end of surgery between the patients with PPCs and non-PPCs as the primary outcome. Considering the data of our preliminary experiment showed that a reduction of dorsal lung ventilation at the end of surgery is 12 ± 6% and hypothesizing 30% of patients experiencing postoperative pulmonary complications and a relative clinically relevant increase in reduction of dorsal lung ventilation of 40% in those with postoperative pulmonary complications, we found that 83 patients were sufficient to evaluate differences between groups (effect size 0.8) with a power of 0.90 and an α error of 0.05. Considering a dropout of 10%, we found a minimum sample size of 92 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
October 7, 2024
CompletedFirst Posted
Study publicly available on registry
October 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2024
CompletedJanuary 3, 2025
December 1, 2024
6 months
October 7, 2024
December 31, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The difference of reduction of dorsal ventilation at the end of surgery between the patients with PPCs and non-PPCs
1. EIT to monitor the regional ventilation of the patients at spontaneous breathing (SB) in the awake state in supine position (T0) and the end of surgery (T3). The reduction of the ratio of dorsal ventilation will be caculated between T3 and T0. 2. Follow-up the patients untill discharge from the hostiptal. Based on whether pulmonary complication occurs during 7 days after surgery, the participants will be divided into the patients with PPCs and the patients with non-PPCs. 3. The difference of reduction of dorsal ventilation at the end of surgery (T3) between the patients with PPCs and non-PPCs will be analyzed.
1-7 days after surgery.
Secondary Outcomes (3)
The difference of reduction of dorsal ventilation at endotracheal intubation after general anesthesia induction between the patients with PPCs and non-PPCs
1-7 days after surgery.
The difference of reduction of dorsal ventilation at pneumoperitoneum and body position change between the patients with PPCs and non-PPCs
1-7 days after surgery.
The risk factors which are associated with PPCs
1-7 days after surgery.
Other Outcomes (1)
The difference of hostpital stays between the patients with PPCs and non-PPC
From the end of surgery to the discharge from hospital, an average of 2 weeks
Eligibility Criteria
Patients undergoing laparoscopic colorectal cancer surgery
You may qualify if:
- Age ≥18 years
- ASA grade I-III
- The patients who are planning to undergo laparoscopic colorectal cancer surgery
You may not qualify if:
- Emergency surgery
- Time of surgery less than 2 hours
- Preoperatively present upper respiratory tract infection or acute pulmonary infection
- Previous history of pulmonary surgery
- Preoperative use of home ventilator
- Inability to perform EIT monitoring
- Declined to participate in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The first Affiliated Hospital, School of Medicine, Zhejiang University.
Hangzhou, Zhejiang, 310000, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Anesthesiology Department
Study Record Dates
First Submitted
October 7, 2024
First Posted
October 29, 2024
Study Start
July 1, 2024
Primary Completion
December 15, 2024
Study Completion
December 25, 2024
Last Updated
January 3, 2025
Record last verified: 2024-12